The main limiting factor in patient retention was adverse drug reactions. Patients taking lamotrigine (LTG) or gabapentin (GBP) did better than those taking carbamazepine. Seizure control was similar among groups. LTG and GBP should be considered as initial therapy for older patients with newly diagnosed seizures.

No abstract

tient selection criteria for this important trial, which could eventually offer another treatment option for patients with aggressive forms of MS previously resistant to more conventional forms of disease-modifying therapy. If the past is a pre-dictor of the future, AHSCT may provide a viable treatment option for patients with RRMS with aggressive breakthrough disease, as well as selected patients with progressive forms of the disease.

No abstract

No abstract